On Nov 2, 2021 Nitrase Therapeutics closed a Series A round and raised $7,000,000 from AbbVie Biotech Ventures, Alexandria Venture Investments, Bristol Myers Squibb, Dementia Discovery Fund, Mission Bay Capital, Sofinnova Partners, featuring lead investors Bristol Myers Squibb.

About the company: Nitrase Therapeutics is located at United States, North America.
“”

Company website: http://www.nitrasetx.com